Over the last century, radiopharmaceuticals have been used extensively in the diagnosis and treatment of various diseases. In cardiology, their main application is for the diagnosis and prognosis of coronary artery disease (CAD). Myocardial perfusion imaging allows the visualization of myocardium via the use of radiotracers. The most common tracers used in SPECT imaging are Thallium-201 (201Tl) and Technetium-99m (99mTc) labeled compounds.
Single Photon Emission Computerize Tomography Single Photon Emission Computerize Tomography Imaging Cardiac Single Photon Emission Computerize Tomography 201Tl Image 99mTc Label Sestamibi
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Baggish AL, Boucher CA. Radiopharmaceutical agents for myocardial perfusion imaging. Circulation. 2008;118:1668–74.PubMedCrossRefGoogle Scholar
Cerqueira MD, et al. Recommendations for reducing radiation exposure in myocardial perfusion imaging. J Nucl Cardiol. 2010;17:709–18.PubMedCrossRefGoogle Scholar
Fazel R. ASNC statement: strategies for defining an optimal risk-benefit ratio for stress myocardial perfusion SPECT. J Nucl Cardiol. 2011;18:385–92.PubMedCrossRefGoogle Scholar
Henzlova MJ, et al. ASNC imaging guidelines: stress protocols and tracers. J Nucl Cardiol. 2009;10:25–37.Google Scholar
Libby P, Bonow RO. Braunwald’s heart disease – a textbook of cardiovascular medicine. 8th ed. St. Louis: Saunders; 2007.Google Scholar